[1]
Pernal, M. et al. 2026. Use of GLP-1 Analogues in Patients with Schizophrenia and Other Neuropsychiatric Disorders: A Literature Review. Quality in Sport. 54, (Apr. 2026), 70410. DOI:https://doi.org/10.12775/QS.2026.54.70410.